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Enterococcus faeciumNRRL B-2354 is a surrogate microorganism used in place of pathogens for validation of thermal process-
ing technologies and systems.We evaluated the safety of strain NRRL B-2354 based on its genomic and functional characteris-
tics. The genome of E. faeciumNRRL B-2354 was sequenced and found to comprise a 2,635,572-bp chromosome and a
214,319-bpmegaplasmid. A total of 2,639 coding sequences were identified, including 45 genes unique to this strain. Hierarchi-
cal clustering of the NRRL B-2354 genome with 126 other E. faecium genomes as well as pbp5 locus comparisons and multilocus
sequence typing (MLST) showed that the genotype of this strain is most similar to commensal, or community-associated, strains
of this species. E. faeciumNRRL B-2354 lacks antibiotic resistance genes, and both NRRL B-2354 and its clonal relative ATCC
8459 are sensitive to clinically relevant antibiotics. This organism also lacks, or contains nonfunctional copies of, enterococcal
virulence genes including acm, cyl, the ebp operon, esp, gelE, hyl, IS16, and associated phenotypes. It does contain scm, sagA,
efaA, and pilA, although either these genes were not expressed or their roles in enterococcal virulence are not well understood.
Compared with the clinical strains TX0082 and 1,231,502, E. faeciumNRRL B-2354 was more resistant to acidic conditions (pH
2.4) and high temperatures (60°C) and was able to grow in 8% ethanol. These findings support the continued use of E. faecium
NRRL B-2354 in thermal process validation of food products.
Enterococcus faecium is a commensal organism of mammaliandigestive tracts and is important for the production of fer-
mented food products, including cheese and sausage (1). Certain
strains of E. faecium were shown to have beneficial, or probiotic,
effects on animal (2–4) and human (5–7) health. However, strains
of E. faecium have also been associatedwith nosocomial infections
(8). Over the past 30 years, the number of enterococcal infections
has increased, with a growing number of illnesses specifically at-
tributed to E. faecium (9). E. faecium infections are of particular
concern because of the high incidence of antibiotic resistance
among many hospital-associated strains. For this reason, E. fae-
cium was identified as an important problem organism requiring
new treatment methods (10).
Recent studies have shown that there is a significant evolution-
ary distance between hospital- and community-associated strains
of E. faecium. Differences between these strains include pheno-
typic (11), gene-specific (12, 13), and whole-genome and pro-
teome level (14–19) distinctions. There are currently over 200
publicly available E. faecium draft genomes. The best-character-
ized genomes are for strain TX16 (also referred to as DO), isolated
from an individual with endocarditis (20), and strain Aus0004,
isolated from the bloodstream of a hospitalized patient (21). Sev-
eral draft genomes of community-associated strains are also cur-
rently available in public databases, but none have been charac-
terized in depth.
The taxonomic classification of E. faecium strain NRRL B-2354
has gone through numerous revisions. It was originally isolated
from dairy utensils in 1927 by G. J. Hucker (22) and in 1960 was
deposited in theU.S. Department of Agriculture (USDA)Agricul-
tural Research Service NRRL culture collection as NRRL B-2354.
In 1979, the strain was placed within the American Type Culture
Collection (ATCC) as Micrococcus freudenreichii ATCC 8459.
However, it was later found to lack many of the characteristics
typical of M. freudenreichii (23) and was reclassified to an unde-
termined species of Pediococcus. Recently, 16S rRNA gene se-
quencing and biochemical assays led to the conclusion that strain
NRRLB-2354 ismost similar tomembers of the E. faecium species
(24), a finding that led to reclassification of the strain assignment
at NRRL and ATCC.
The thermal tolerance of E. faecium NRRL B-2354 on al-
monds is similar to that of Salmonella enterica serovar Enteritidis
phage type 30. This strain is recommended and widely used as a
surrogate for Salmonella in the validation of commercial thermal
processes that are used for almonds (25–28). E. faecium NRRL
B-2354 is also considered to be a suitable surrogate for food-borne
pathogens in thermal processes used for dairy products (29), juice
(30), and meat (24). Surrogate organisms are inoculated into or
onto food products that are subsequently sent through food pro-
cessing equipment located in commercial food processing facili-
ties. Because of the risks associated with introducing a pathogen
into a food processing facility, it is preferred to use a nonpatho-
genic surrogate organism that has been adequately characterized.
Despite the long history of use of E. faecium NRRL B-2354 as a
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surrogate, concern over E. faecium in clinical settings supports the
need to further evaluate the characteristics of this particular strain.
Therefore, we examined the genome of E. faecium NRRL B-2354
for the presence of virulence factors, evaluated the expression of
those genes and environmentally relevant phenotypes, and quan-
tified resistance to several clinically important antibiotics.
MATERIALS AND METHODS
Bacterial strains and culture conditions. E. faecium NRRL B-2354 was
obtained from the USDA Agricultural Research Service Culture Collec-
tion (Peoria, IL; receiving date, 22 July 2011; http://nrrl.ncaur.usda.gov).
E. faeciumATCC 8459 (receiving date, 26 July 2011), Enterococcus faecalis
ATCC 29212 (receiving date, 26 July 2011), and Bacillus cereus ATCC
14579were obtained from the American Type Culture Collection (ATCC,
Manassas, VA). E. faecium TX0082 was provided by Barbara Murray
(University of Texas Medical School, Houston). E. faecium 1,231,502 was
providedMichael Gilmore (Harvard University, Boston, MA). Enterococ-
cus strains were routinely cultured in brain heart infusion (BHI) agar or
broth (dehydrated medium; Difco, Becton, Dickinson [BD], Franklin
Lakes, NJ), incubated overnight at 37°C.
DNA sequencing, assembly, and annotation. One colony of E. fae-
cium NRRL B-2354 strain was inoculated into 15 ml of BHI broth and
incubated at 37°C under static conditions for 8 h. Cells were harvested by
centrifugation and washed twice with phosphate-buffered saline (PBS; 80
g NaCl, 2 g KCl, 26.8 g Na2HPO4 · 7H2O, and 2.4 g KH2PO4 in 800 ml
H2O, pH 7.3). Genomic DNA was extracted using the DNeasy Blood &
Tissue kit (Qiagen, Valencia, CA) according to the manufacturer’s in-
structions.
A 500-bp insert library was prepared for 100-bp, paired-end sequencing
in the IlluminaHiSeq 2000 as previously reported (31). A total of 4,044Mbp
of100-bppaired-endreadswereobtainedandwerequalityfilteredataquality
score of20 at each nucleotide position. After quality filtering, 656 Mbp of
80-bp or longer Illumina reads was obtained. The filtered reads (80 bp)
were assembled into contigs by using the Ray 1.7 sequence assembler (32)
with a 31-bp k-mer. The filtered Illumina reads were assembled into 49 con-
tigs (100 bp; total length, 2,841,503 bp; average length, 57,989 bp; maxi-
mum length, 198,831 bp; N50 length, 138,902 bp; GC content, 37.84%). The
genomic DNA was also sequenced using the PacBio RS sequencer with C2
chemistry (190minand245min)(21).PacBioRSsequencingproduced
a total of 292 Mbp with an average length of 2,328 bp (maximum length,
14,914 bp; N50 length, 3,385 bp) after removing adaptor sequences. PacBio
reads 6 kbp or longer were used to close gaps between the contigs. Errors
found in PacBio reads were corrected by using the Illumina reads (33). All
DNA sequencing was performed at the UC Davis Genome Center (http:
//www.genomecenter.ucdavis.edu).
The gap-closed and error-corrected genome sequences were anno-
tated for protein coding sequences (CDS), rRNA genes, and tRNA genes
by manual annotation and by Rapid Annotation Using Subsystem Tech-
nology (RAST) (34), RNAmmer 1.2 Server (35), and tRNAscan-SE 1.21
(36) with default options for bacteria. The genome was also screened for
the presence of antibiotic resistance (AR) genes found in the Antibiotic
Resistance Database (ARDB) (37).
Hierarchical clustering and phylogenetic analysis. A total of 126 ge-
nome sequences and annotations for 125 E. faecium strains, including two
versions of the E. faeciumDO (TX16) genome were obtained from public
databases in April 2013 (see Table S1 in the supplemental material). The
genomes were screened for 7,017 orthologs of protein coding sequences
identified in a previous report (19). For hierarchical clustering of E. fae-
cium strains, gene ortholog distances between two strains were calculated
according to the Euclidean distance method. Bootstrapping was per-
formed using Pvclust with a 10,000 resampling option (38).
Phylogenetic comparisons of PBP5 protein sequences (39) andmulti-
locus sequence typing (MLST) for seven housekeeping genes (adk, atpA,
ddl, gdh, gyd, pstS, and purK) (40) were performed for all E. faecium ge-
nomes using MEGA 5 (41).
Circular genome alignment. E. faecium genome sequences were frag-
mented into 500-bp sequences and then aligned to the E. faecium NRRL
B-2354 genome as a reference using GASSST (42). The alignment was
visualized in concentric circles using perl scripts. Protein coding se-
quences, tRNA, rRNA, AR genes (37), virulence factor (VF) genes (8), and
mobile elements (ME) were designated as previously described (19). ME
elements included phage genes or transposon, transposase, integrase, and
insertion sequences (IS) based on the genome annotations. Genes with
GC contents that were high (GC%  mean  1.5  standard deviation
[SD]) or low (GC%mean 1.5 SD) were also identified.
Detection of virulence-associated genes. Certain Enterococcus VF genes
were examined for their presence in the NRRL B-2354 genome by using
NCBI BLAST (43). The presence of esp, gelE, and hylwas also examined
by PCR according to previously described protocols (44, 45) (see Table S2
in the supplemental material). Positive controls used for PCR were E.
faecalis ATCC 29212 (gelE) and E. faecium 1,231,502 (esp and hyl).
Electron microscopy. Negative staining was accomplished with
standard techniques utilizing 1% ammonium molybdate (46). Trans-
mission electron microscopy was performed with a Philips CM120
Biotwin lens (FEI Company, Hillsboro, OR), and the camera used was a
GatanMegaScanmodel 794/20 digital camera (2K 2K; Pleasanton,CA).
Microscopy and staining were performed at The University of California,
Davis, School of Medicine, Department of Pathology and Laboratory
Medicine, Electron Microscopy Lab.
Production of gelatinase and hemolysin. The ability to hydrolyze
gelatin was determined by examining for zones of turbidity around colo-
nies after growth overnight at 37°C on Todd-Hewitt agar supplemented
with 3% (wt/vol) gelatin (47). Hemolysin wasmeasured by examining for
zones of clearing around colonies after growth overnight at 37°C on tryp-
tic soy agar (TSA) supplemented with 5% (vol/vol) defibrinated horse
blood (47).
Adherence to collagen type I.Adhesion to collagenwas evaluated using
a previously described method (48), with several modifications. Rat tail col-
lagen (type I) in 0.02M acetic acid (BD) at a concentration of 15g per well
was used. E. faecium cells from overnight cultures grown in BHI broth
were collected by centrifugation at 805 g, suspended in PBS to an optical
density at 600 nm (OD600) of 1.0, and added to the wells. Adhesion was
calculated according to relative absorbance in a microplate spectropho-
tometer (Biotek, Winooski, VT) as follows: OD595(collagenBSAbacteria)
OD595(BSAbacteria).
Adherence to fibrinogen and fibronectin. The ability to adhere to
fibrinogen and fibronectin was examined using previously described
methods (49), except that 200 l human fibrinogen (Calbiochem, Merck
KGaA, Darmstadt, Germany) in 50 mM sodium carbonate buffer (pH
9.6), 15g perwell, or 200l fibronectin (Calbiochem) in 50mMsodium
carbonate buffer (pH 9.6), 15 g per well, was used.
Biofilm formation on polystyrene. The ability of cells to adhere to
polystyrene plateswas evaluated using a previously describedmethod (50)
with several modifications. Cells were grown overnight in BHI broth at
37°C, and 200l of a 1:20 dilution of the cultures in BHI broth was added
to a sterile 96-well polystyrene microtiter plate (BD). After incubating for
24 h at 37°C, wells were washed three times with PBS, dried in an inverted
position for 15min, and stainedwith 1% (wt/vol) crystal violet for 15min.
Thewells were rinsed againwith PBS, and the crystal violet was solubilized
in 200 l of an ethanol and acetone solution (80:20, vol/vol). The OD595
was determined using a microplate spectrophotometer (Biotek).
Antibiotic susceptibility testing. Antibiotic resistance was deter-
mined at the University of California, Davis Medical Center Clinical
Laboratory, Sacramento, CA (http://www.ucdmc.ucdavis.edu/pathology
/services/), using the BD Phoenix 100 Automated Microbiology system
(BD).
Survival at low pH, at high temperature, or in the presence of etha-
nol. For acid and thermal stress tolerance tests,E. faecium strainswere first
grown in BHI overnight at 37°C and washed twice in physiological saline
(0.85% [wt/vol] NaCl, pH 7). Tomeasure survival at low pH, washed cells
Kopit et al.
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were suspended in physiological saline with an adjusted pH of 2.4 (acidi-
fied with 5 M HCl). Suspensions were sampled at 10-min intervals for 60
min, and serial dilutions were prepared in physiological saline for plating
onto BHI agar. Plates were incubated at 37°C overnight for CFU enumer-
ation. Thermal tolerance was determined by dispensing 50 l of the E.
faecium cells in physiological saline (pH 7) into 200 l microcentrifuge
tubes and incubating in a C1000 Thermal Cycler (Bio-Rad Laboratories,
FosterCity, CA) at either 50°Cor 60°C.Cell survival was determined every
10 min for 60 min by CFU enumeration using serial dilutions of separate
50-l aliquots cooled to 21 to 23°C. Ethanol tolerance was determined by
incubation of approximately 107 E. faecium cells at 37°C in BHI broth
adjusted to contain either 12% (vol/vol) additional water or 8% or 12%
(vol/vol) ethanol. Growthwasmeasured at anOD600 every 15min over 24
h in a microplate spectrophotometer (Biotek).
Nucleotide sequence accession numbers. The genome sequence and
gene annotation information have been deposited at GenBank under the
accession numbers CP004063 (chromosome) and CP004064 (plasmid
pNB2354_1).
RESULTS
Genome sequencing, assembly, and annotation of E. faecium
NRRL B-2354. The genome of E. faecium NRRL B-2354 was se-
quenced, assembled, and annotated to yield one chromosome
(2,635,572 bp) and one plasmid (214,319 bp, designated pNB2354_1)
(see Fig. S1 and Table S3 in the supplemental material). The GC
content of the NRRL B-2354 chromosome (38.03%) is similar to
that of other E. faecium strains, including TX16 (also known as
DO) (38.15%) (20) and Aus0004 (38.36%) (21). The GC content
of the plasmid is lower (35.98%) than that of the chromosome but
similar to that of themegaplasmids of other E. faecium strains (see
Table S3 in the supplemental material). A total of 2,639 CDS, 18
rRNA (5S, 16S, and 23S), and 49 tRNA genes were predicted in the
assembled annotated genome (see Table S3). The genome of the
clonal deposit of this strain at the ATCC, strain ATCC 8459, was
also sequenced and found to share over 99% sequence identity
with the strain NRRL B-2354 (data not shown).
Hierarchical clustering and phylogenetic analysis. Hierar-
chical clustering was performed using strain NRRL B-2354 and
126 other E. faecium genome sequences according to the presence/
absence of orthologous genes as previously described (19). The
genome of strain NRRL B-2354 clustered with other nonclinical
(NC), or community, E. faecium isolates in a clade containing few
clinical (CL) strains (Fig. 1). Specifically, the NRRL B-2354 ge-
nome clustered with other community E. faecium strains in the
NC2 clade. This newly described clade is significantly enriched in
nonclinical strains (P 0.036, Fisher’s exact test) amongwhich 26
of the 32 strains available for comparison had nonclinical, or com-
munity, origins. The genome of E. faecium NRRL B-2354 was
most similar to that of strain E1050, a fecal isolate from a healthy
volunteer.
Gene-targeted comparisons using the pbp5 gene and MLST
were also performed to further evaluate the relationships between
E. faeciumNRRL B-2354 and other E. faecium strains. The pbp5-R
genotype is associatedwith ampicillin resistance, and PBP5 amino
acid sequences separated E. faecium strains into two different
clades (39, 51). A phylogenetic tree of PBP5 protein sequences
from E. faecium strains showed that the PBP5 amino acid se-
quence of strainNRRLB-2354 clustered together withmany com-
munity-associated (nonclinical) strains of strains belonging to the
NC2 clade (see Fig. S2 in the supplemental material). Notably,
these strains along with NRRL B-2354 exhibit a pbp5-R genotype
(51).
In contrast, MLST analysis did not show clear NC and CL
strain separation (see Fig. S3 in the supplemental material). Ex-
amination of the E. faecium NRRL B-2354 genome revealed that
this strain belongs in sequence type ST32 according to six of the
seven housekeeping genes used for sequence typing (atpA, ddl,
gdh, gyd, pstS, and purK). This MLST pattern is highly associated
with NC E. faecium strains, unlike other sequence types (ST) (see
Table S4 in the supplemental material). Sequence comparisons of
adk, the remaining gene commonly used for enterococcal MLST,
identified a single-nucleotide change in this gene in NRRL B-2354
compared to the other members of ST32. Because this difference
might represent a novel MLST group, strain NRRL B-2354 was
assigned a novel sequence type (ST860) in the E. faecium MLST
database (http://efaecium.mlst.net/) (40) (see Table S1 in the sup-
plemental material).
Unique genes in theNRRLB-2354 genome.Genome compar-
isons identified 45 unique genes in NRRL B-2354 not present in
the other 125 E. faecium strains examined. These genes are colo-
calized in the genome in five locations (designated SP1 to SP5)
(Fig. 2). Many of the genes specific to strain NRRL B-2354 areME
or colocalized toME genes (Fig. 2; see Table S5 in the supplemen-
tal material). A total of 25 of the 45 genes have functional assign-
ments and include a putative glycosyltransferase, an amidohydro-
lase domain protein, a transcriptional antiterminator, a DEAD/
DEAH box helicase-like protein, and DNA repair protein RadC
(Fig. 2; see Table S5 in the supplemental material).
Antibiotic resistance and related genes inNRRLB-2354.An-
tibiotic resistance genes were not found in the NRRL B-2354
genome (Fig. 2 and Table 1). Based on MICs, E. faecium NRRL
B-2354 is sensitive to vancomycin, streptomycin, gentamicin, and
ampicillin (Table 1), antibiotics commonly used separately or in
tandem to treat enterococcal infections (52). The strain exhibited
intermediate sensitivity to erythromycin and was sensitive to the
cephalosporins cefoxitin and cefazolin, despite cephalosporin re-
sistance being intrinsic to most enterococci (53) (Table 1).
Presenceof cas and thenumberofAR,VF, andMEgenes.The
genome of E. faeciumNRRLB-2354 lacks cas genes encoding clus-
tered regularly interspaced short palindromic repeat (CRISPR)-
associated proteins involved in bacterial immunity against foreign
DNA (54). For at least certain E. faecium strains, the number of cas
genes is negatively correlated with the number of AR genes (55).
To examine whether this trait was common to E. faecium from
bothNC andCL origins, the numbers of AR genes were compared
among strains lacking CRISPR-cas systems. Notably, cas-negative
NC strains contained significantly lower numbers of AR genes
thandid strainswith aCLbackground (Fig. 3). The numbers ofVF
andMEgenes are also significantly lower inNC than inCL isolates
(Fig. 3). Such observations were not statistically examined for cas-
positive E. faecium strains due to the low number of those strains
for which genome sequences were available.
Virulence factors. The E. faeciumNRRL B-2354 genome lacks
several genes encoding VF that are associated with this species
(Table 2). Specifically, IS16, a common marker of hospital-asso-
ciated strains (56), is absent from strain NRRL B-2354, as are
genes coding for gelatinase (gelE) (57), hyaluronidase (hyl) (58),
cytolysin (cyl) (59), and a virulence and biofilm formation protein
(esp) (60). These VF are commonly found in hospital-associated
strains of E. faecium (47). The in silico findings for several of these
Safety of E. faecium NRRL B-2354
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genes were confirmed by PCR (data not shown). The absence of
gelE was also confirmed by the inability of E. faecium NRRL
B-2354 to hydrolyze gelatin during growth on laboratory culture
medium(seeFig. S4 in the supplementalmaterial).Althoughanother
putative hemolysin (AGE29035) was annotated in the genome of E.
faecium NRRL B-2354, hemolytic activity was not detected for E.
faecium NRRL B-2354 (see Fig. S4 in the supplemental material).
The scm gene encoding a collagen I and IV adhesion (61) and
the acm gene encoding a collagen I adhesion associated with en-
docarditis (62) were found in strain NRRL B-2354 (Table 2). Al-
though scm appeared to be intact, acm contained a 1,059-bp in-
sertion 52 bp into the coding region of the gene (Fig. 4A; see Fig. S5
in the supplemental material). This insertion is an integrase that
shares 100% nucleotide identity with an integrase from E. faecium
Aus0004 (21). The integrase contains many stop codons in the
reading frame of acm (Fig. 4A), indicating that acm is not ex-
pressed. Strain NRRL B-2354 and its clonal relative ATCC 8459
also adhered to collagen in significantly smaller amounts than E.
faecium TX0082 (ST17) (Fig. 4B). E. faecium TX0082 (ST17) con-
tains an intact acm gene and was previously shown to bind colla-
gen (63).
Pili are associated with enterococcal virulence and biofilm for-
mation (64, 65). Strain NRRL B-2354 contains genes in the ebp
and pil operons coding for pilus production (65, 66) (Table 2).
FIG 1 Hierarchical clustering of 127 E. faecium genomes. Genome comparisons were based on the presence/absence of 7,017 orthologs found in the E. faecium
pangenome. Nonclinical strains are labeled in blue, clinical strains in red, and strains with unidentified origins in black. An artificial outlier was included. Strain
NRRL B-2354 is indicated by an asterisk. Red and green values in certain nodes indicate approximately unbiased and biased probabilities for the bootstrapping,
respectively.
Kopit et al.
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However, the transcriptional regulator ebpR, the promoter for the
cotranscribed ebpA, ebpB, and ebpC genes, and the first 688 bp of
ebpA are absent from strain NRRL B-2354 (Fig. 5A). In total, the
deletion encompasses approximately 2 kb in comparison to strain
TX0082, a strain confirmed to produce pili encoded by the ebp
operon (65). Similarly, pili were detected on the surface of TX0082
but not E. faecium NRRL B-2354 (see Fig. S6 in the supplemental
material).
Because ebp-encoding pili are associated with biofilm forma-
tion (65), the capacity of the strains to form biofilms on polysty-
rene was alsomeasured. Biofilm formation according to cell stain-
ing intensities was 5-fold lower for strains NRRL B-2354 and
ATCC8459 than for TX0082 (Fig. 4B).Notably,E. faeciumB-2354
has a reduced capacity to form biofilms even though it contains
efaA, a manganese-dependent gene encoding an endocarditis-
specific antigen involved in biofilm formation (67, 68) (Table 2).
E. faeciumNRRL B-2354 contains sagA, a virulence gene asso-
ciatedwith endocarditis (Table 2) (69). SagAcontributes tobinding
to fibrinogen, fibronectin, and collagen type I and IV laminin (70)
and is also present in TX0082 (67). Accordingly, both E. faecium
strains as well as ATCC 8459 bound to fibrinogen and fibronectin
at similar levels (see Fig. S7 in the supplemental material).
Tolerance to low pH, heat, and ethanol.After 20min of incu-
bation at pH 2.4, E. faecium NRRL B-2354 survived in 10- and
100-fold-larger amounts than the clinical strains TX0082 and
1,231,502 (ST203) (Fig. 6A). Within 50 min of incubation at the
acidic pH, NRRL B-2354 exhibited only a 3-log decline, whereas
viable cell numbers of the two clinical isolates were reduced by 7
log (Fig. 6A).
Incubation at 50°C for 60 min was not detrimental to the via-
FIG 2 Alignment of 127 E. faecium genomes. (A) Circular alignment of E. faecium genomes. The outside of the circle is the NRRL B-2354 reference genome to
which the other genomes are aligned.Genes identified as potential VF inNRRLB-2354 are indicated. Loci unique toNRRLB-2354 are also indicated (SP1 to SP5).
(B) Key to circular alignment map. Gene types and strain origins are depicted in the same order (outwards to inwards) in the circular map. AR, antibiotic
resistance genes; VF, virulence factors; ME, mobile genetic elements.
TABLE 1 Antibiotic resistance of E. faecium NRRL B-2354a
Class and
antibiotic
MIC
(mg/liter) Sensitivity
No. of screened AR gene
types from ARDBc
Aminoglycosides
Gentamicin Sensitiveb Sensitive 737
Streptomycin Sensitiveb Sensitive 869
Cephalosporins
Cefazolin 2 Sensitive 1,393
Cefoxitin 8 Sensitive 844
Glycopeptides
Vancomycin 0.5 Sensitive 300
Macrolides
Erythromycin 2 Intermediate 1,092
Penicillins
Ampicillind 0.125 Sensitive 1,896
Penicillin 1 Sensitive 1,896
Quinolones
Levofloxacin 2 Sensitive 273
Tetracyclines
Minocycline 1 Sensitive 597
Tetracycline 0.5 Sensitive 597
a The same results were found for E. faecium ATCC 8459.
b Numerical MICs were not determined.
c No AR genes were detected in our study; ARDB data are from reference 37.
d Certain pbp5 genotypes are associated with ampicillin resistance in E. faecium, but
they were not considered here because of the variation in ampicillin resistance and
sensitivity phenotypes among strains containing this gene.
Safety of E. faecium NRRL B-2354
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bility of E. faecium NRRL B-2354, TX0082, and 1,231,502 (Fig.
6B). At an incubation temperature of 60°C for 10min, there was a
decline of over 7 log in viability of strains TX0082 and 1,231,502
(Fig. 6B). In contrast, a 2-log decline was observed for NRRL
B-2354 after 60 min at 60°C (Fig. 6B).
E. faecium NRRL B-2354, TX0082, and 1,231,502 were unable
to grow in BHI in the presence of 12% ethanol (data not shown).
When the culture medium contained 8% ethanol, only NRRL
B-2354 was able to grow (Fig. 6C). E. faecium NRRL B-2354 ex-
hibited a longer lag phase in this medium, and the cells reached a
1.3-fold-lower final optical density than did cells grown in BHI
lacking ethanol (data not shown).
DISCUSSION
E. faecium NRRL B-2354, a commonly used strain with a long
history in food products and thermal process validation, lacks the
FIG 3 Numbers of AR, VF, and ME genes in strains with or without cas genes. Three types of genes, AR (A), VF (B), and ME (C), that have important roles in
virulence of E. faecium were counted and compared statistically between CL and NC E. faecium strains (Student’s t test). Strains with unidentified origins (UN)
were also shown for reference. The arrow indicates the value of NRRL B-2354 in each panel.
TABLE 2 Presence of virulence factors in E. faecium NRRL B-2354
Genea Function
Length of reference
gene (bp) % Coverage
Nucleotide
identity (%) Reference
acm Adhesion to collagen and other extracellular proteins 2,166 100 99 64
cyl Cytolysin, hemolysis 7,500 NDb ND 60
ebpR Regulatory gene for enterococcus biofilm and pilus (ebp) operon 1,392 ND ND 65
ebpA Pilin subunit 3,390 80 99 65
ebpB Pilin subunit 1,422 100 99 65
ebpC Pilin subunit 1,878 100 99 65
efaAfm Adhesion protein, plays role in endocarditis 951 100 100 68
esp Enterococcal surface protein 2,315 ND ND 61
gelE Gelatinase 6,088 ND ND 58
hyl Hyaluronidase 1,662 ND ND 59
IS16 Mobile insertion sequence 1,188 ND ND 57
pilA Major pilin subunit 1,977 100 99 67
pilE Secreted surface protein 756 100 100 67
pilF Minor pilin subunit 2,091 100 99 67
sagA Adhesion protein 1,575 100 100 70
scm Surface protein, adhesion to extracellular proteins 1,983 100 100 62
a The E. faecium NRRL B-2354 genome was compared to the E. faecium TX16 (DO) genome, except for the following: E. faecium Aus0004 (esp), E. faecalis V583 (cyl, gelE), E.
faecium U37 (IS16), and E. faecium E1165 (pilA, pilE, pilF).
b ND, not detected.
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majority of virulence factors known for this species and is sensitive
to medically relevant antibiotics. These features are consistent
with its genomic relationship to nonclinical (NC), or community,
strains of E. faecium. Overall, the findings of this study support the
continued use of E. faecium NRRL B-2354 and its clonal relative
ATCC 8459 in the validation of processing equipment used for
thermal treatment of food products.
Comparative genomics approaches have previously concluded
that there is a significant evolutionary distance between clinical
and community isolates of E. faecium (11–19). In the present
study, whole-genome, PBP5, and MLST comparisons revealed
thatE. faeciumNRRLB-2354 ismost similar to nonclinical strains.
This result is in agreement with the original isolation of E. faecium
NRRL B-2354 from dairy utensils. Among nonclinical strains,
NRRL B-2354 belongs to the newly identified NC2 clade (34).
Although the origins ofNC2 are currently unclear (16, 17, 19), it is
notable that NC2 strains share similar PBP5 amino acid sequences
associated with ampicillin resistance. Divergence of NC2 clade
strains, includingNRRLB-2354,might therefore be in accordance
with pbp5 evolution.
E. faeciumNRRL B-2354 contains 45 unique genes not present
in the 125 other E. faecium genomes examined here. The majority
of these genes encode phage-associated proteins or have unknown
function. These genes were distributed among five loci (SP1 to
SP5) throughout the genome, suggestive of separate gene integra-
tion events. Further investigation is needed to elucidate whether
these genes confer unique functionality to NRRL B-2354, partic-
ularly with regard to its association with dairy products and high
levels of environmental stress tolerance.
Like other NC strains, E. faeciumNRRL B-2354 has fewer ME,
AR, and VF genes than strains isolated from clinical settings. A
lower abundance of those genes is also related to the smaller ge-
nome sizes ofNC strains (16, 19). In contrast to the lownumber of
ME, NRRL B-2354 lacks CRISPR-cas systems associated with pro-
tection againstME-associated foreign DNA, including AR and VF
genes (55). The significantly lower number of ME in cas-negative
NC strains supports the possibility that other factors are also im-
portant to ME susceptibility in E. faecium.
The lack of AR genes in E. faecium NRRL B-2354 is in agree-
ment with the sensitivity of this strain to medically relevant anti-
biotics, including but not limited to vancomycin. Although this
strain contains a pbp5-R allele, it is also sensitive to ampicillin.
Resistance of E. faecium to either vancomycin or ampicillin se-
verely limits treatment options for enterococcal infections. While
strain NRRL B-2354 exhibited an intermediate level of resistance
to erythromycin, this trait is common among other food-associ-
ated E. faecium (71).
E. faecium NRRL B-2354 also lacks or contains nonfunctional
copies of the majority of known and established enterococcal vir-
ulence factors. This includes esp, hyl, and IS16 commonly found in
clinical isolates (56, 72). Those loci were specified by the European
Food Safety Authority (EFSA) as targets for the safety evaluation
of E. faecium strains intended as additives for animal feed (73).
EFSA recommends examining for the presence of esp, hyl, and
IS16 as well as sensitivity to ampicillin as exclusion criteria (73). E.
faeciumNRRLB-2354 lacks these genes and, as discussed above, is
sensitive to ampicillin. Therefore, this strain meets the require-
ments for safety by the EFSA guidelines. These results were shared
with American Type Culture Collection and were deemed suffi-
cient for ATCC to classify the clonal strain in the biosafety level 1
(BSL-1) category (Brian Beck, ATCC, personal communication).
Furthermore, based on this information, USDA agreed to remove
FIG 4 NRRLB-2354 acm gene insertion and impaired collagen adherence. (A) Schematic diagram of the acm gene in E. faeciumNRRLB-2354 and clinical strain
E. faeciumTX0082. The genes are 99% identical in the coding regions (gray); however, a 1,059-bp insertion sequence (hatched lines) is located 52 bp from the start
codon inNRRLB-2354. (B)E. faecium binding to type I collagen. Absorbancewas significantly higher for TX0082 than for the other two strains (Tukey’s honestly
significant difference [HSD], P 0.05). The averages	 SD of three replicates per strain are shown.
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reference to BSL-2 for NRRL B-2354 (ToddWard, personal com-
munication).
Additionally, we examined theNRRLB-2354 genome for other
E. faecium VF, including secreted enzymes and cell surface pro-
teins. Genotype and phenotype assessments confirmed that E. fae-
cium NRRL B-2354 lacks the capacity to produce gelatinase and
cytolysin. These enzymes are most often found in CL-associated
strains of E. faecium and have been directly linked to enterococcal
virulence in animal models of infection (74, 75). Cell surface pro-
teins associated with enterococcal virulence include functions in
biofilm formation and adhesion to extracellular matrix proteins
such as collagen, fibrinogen, and fibronectin (65, 76). E. faecium
NRRL B-2354 contains partial or nonfunctional copies of acm
encoding a collagen I adhesin and the ebp operon for pilus pro-
duction.
E. faecium NRRL B-2354 does contain complete and hence
likely functional copies of sagA, scm, efaA, and the pilA operon.
The majority of these genes apparently did not contribute to the
phenotypes tested here (i.e., collagen adherence, pilus production,
and biofilm formation). Overall, these genes are not as well char-
acterized as other known E. faecium virulence determinants (8).
Although NRRL B-2354 adhered to fibrinogen and fibronectin,
possibly through SagA, this phenotype has also been described for
probiotic Lactobacillus strains (77, 78) and has been detected for
dairy-associated strains of E. faecium (79). Such functions might
be important for intestinal colonization and regarded as “niche
factors,” as has been suggested for probiotic lactobacilli (80).
Unlike the clinical strains TX0082 and 1,231,502, E. faecium
NRRL B-2354 exhibited a heightened capacity to survive environ-
mental stresses. These are useful characteristics for a surrogate
microorganism which should exhibit levels of stress tolerance
similar to those of the human pathogens that they are intended to
mimic, such as strains of Salmonella. Stress tolerance in lactic acid
bacterium relatives of E. faecium is due to a variety of metabolic
and stress response pathways (81, 82). It is notable that E. faecium
NRRL B-2354 exhibited superior acid, heat, and ethanol stress
tolerance levels, possibly indicating that similar mechanisms are
involved in conferring to this strain the capacity to survive/grow
under those conditions. E. faecium NRRL B-2354 contains nu-
merous genes coding for stress-responsive proteins, including an
FoF1 ATPase, certain transcriptional regulators (ctsR), and chap-
erones and proteases (dnaK, groEL, grpE, ftsH, htrA, clpB, clpC,
clpE, clpP, and clpX) (data not shown). However, the genomes of
the hospital-associated strains TX0082 and 1,231,502 also contain
the majority of these genes. Hence, future studies should investi-
gate the specific mechanisms by which E. faecium NRRL B-2354
and not TX0082 and 1,231,502 can survive environmental
stresses. This information would also be useful for predicting
which organisms would be suitable surrogates.
Despite its common occurrence in foods, E. faecium has not
been causally linked to food-borne infection (1). Instead, experi-
mental and clinical infections caused by this species appear to be
the result of contact by certain strains of this species to extraintes-
tinal sites on the body through catheters, surgeries, or poor sani-
tation (8). Hence, E. faeciumNRRL B-2354 presents a clear exam-
ple of the need for strain- and application-specific evaluations
rather than species level designations on safety. Future studies
should further clarify the exact mechanisms of E. faecium patho-
genesis and distinguish between strains that have acquired distinct
FIG 5 Ebp locus and biofilm formation in E. faecium NRRL B-2354. (A) Schematic diagram of the ebp operon in E. faecium NRRL B-2354 and TX0082.
(B) E. faecium biofilm formation on polystyrene. Absorbance was significantly higher for TX0082 than for the other two strains (Tukey’s HSD, P 0.05). The
averages	 SD of three replicates per strain are shown.
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traits for colonization of extraintestinal sites on the human body
and those that benefit food safety and human health.
Presently, there are few bacterial surrogate strains available to
validate processes used to control food-borne pathogens in food
processing (83, 84). As for any bacterial strain, E. faecium NRRL
B-2354 should be handled with appropriate care; however, it lacks
the genomic and phenotypic characteristics that define strains of
this species responsible for nosocomial infections. The data pre-
sented here along with the long history of safe use of E. faecium
NRRLB-2354 and its clonal representative ATCC8459 support its
continued role in the safe production of foods.
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